Evolving Immuno-Chemotherapeutic Paradigms in Esophageal and Gastric Cancers
Esophageal (EC) and gastric (GC) cancers represent severe global health issues. Within the last 18 months, the standard of care has significantly evolved for the first-line setting of advanced EC and GC within the field of human epidermal growth factor receptor 2 (HER2)-negative and HER2-positive pa...
Saved in:
| Main Author: | Alexander Siebenhuener |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
THE HEALTHBOOK COMPANY LTD.
2021-12-01
|
| Series: | healthbook TIMES. Oncology Hematology |
| Online Access: | https://doi.org/10.36000/hbT.OH.2021.10.054 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immuno-informatics analyses of important esophageal cancer associated viruses for multi-epitope vaccine design
by: Zafer Saad Al Shehri
Published: (2025-07-01) -
Expression of MxA in esophageal cancer cell lines can influence sensitivity to chemotherapeutic agents but this does not require apoptosis
by: R. M. Hayes, et al.
Published: (2024-09-01) -
The Evolving Paradigm in the Management of Intracranial Atherosclerotic Disease
by: Ali K. Ozturk, et al.
Published: (2012-01-01) -
The First Comprehensive Evaluation of Immuno-Inflammatory Markers for Prognosis in Esophageal Cancer Patients: A South Asian Perspective
by: Sajida Qureshi, et al.
Published: (2024-10-01) -
Prognostic value of immuno-inflammatory biomarkers in esophageal squamous cell carcinoma patients receiving immunotherapy combined with chemoradiotherapy and its association with immuno-genomic landscape
by: Xingyuan Cheng, et al.
Published: (2024-12-01)